Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07216911 · ClinicalTrials.gov registry record · NA
Evaluating the Impact of Psychotherapeutic Advertising Claims on Cannabis Purchasing
A NA study, sponsored by Trustees of Dartmouth College.
- Recruiting
- Registry status
- NA
- Development phase
- 2,000
- Enrollment target
NCT07216911: Recruiting NA study, sponsored by Trustees of Dartmouth College.
NCT07216911 is a NA study that is actively recruiting participants, run by Trustees of Dartmouth College. The registered enrollment target is 2,000 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07216911, a NA study, is actively recruiting participants, sponsored by Trustees of Dartmouth College.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,000 participants
- Enrollment target
Study Summary
In the U.S., legal cannabis is frequently advertised as an effective treatment for mental health problems such as anxiety and depression-particularly online. States that have legalized cannabis have not implemented regulations to address this type of advertising. This project aims to investigate the influence of psychotherapeutic advertising claims (PAC) and mental health warning labels (WL) on online cannabis purchasing behaviors among light-to-moderate cannabis users with symptoms of depression and/or anxiety. The specific aims are to determine whether PAC increases cannabis purchasing intentions and whether a mental health WL can mitigate this effect. A realistic online cannabis shopping experience will be simulated using the digital Platform for Online Evaluation of Marijuana Marketing and Sales (POEMMS). The study will employ a between-subjects experimental design by randomizing 2,000 participants to one of four online stores that vary in PAC and WL content: (1) a control claims (CC)-only store, (2) a PAC store, (3) a WL store, and (4) a PAC + WL store. Participants will browse and select items as if making real purchases. Analyses will examine three primary outcomes to determine the influence of PAC and WL on purchasing behaviors: (1) total milligrams of THC purchased, (2) average potency (%THC) of products, and (3) overall number of products purchased. The long-term objective is to inform evidence-based cannabis policy and regulatory strategies by understanding the impact of cannabis marketing on vulnerable populations. This research is relevant to public health by addressing the potential risks associated with misleading cannabis marketing, which may lead to increased use and exacerbation of mental health symptoms among individuals with depression and anxiety. The project leverages a multidisciplinary team with expertise in addiction, mental health, epidemiology, and digital health technology. The findings have the potential to inform the development of t
Primary Outcome
This outcome measures the cumulative amount of Δ⁹-tetrahydrocannabinol (THC) that participants select during their shopping session in the simulated online cannabis store. THC is the primary psychoactive compound in cannabis, and its quantity is a critical factor in understanding purchasing behavior. Rationale: Measuring total mgTHC allows us to assess whether exposure to PAC or WL influences the overall amount of THC that participants intend to consume. This is important because higher THC con
Interventions
- BEHAVIORAL CC
- BEHAVIORAL PAC
- BEHAVIORAL WL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2026-04-15 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT07216911 shows while recruiting
NCT07216911 is an interventional study that assigns participants to a tested intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% higher).
The record links to 0 conditions, and to 3 interventions - of which CC is the first listed.
NCT07216911 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07216911 about?
NCT07216911 is a clinical study titled "Evaluating the Impact of Psychotherapeutic Advertising Claims on Cannabis Purchasing". In the U.S., legal cannabis is frequently advertised as an effective treatment for mental health problems such as anxiety and depression-particularly online. States that have legalized cannabis have not implemented regulations to address this type of advertising. This project aims to investigate the...
What is the current status of trial NCT07216911?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,000 participants. The study started on 2026-04-15. Estimated completion is 2027-06-30.
What interventions are being tested in trial NCT07216911?
The interventions under investigation include: CC (BEHAVIORAL), PAC (BEHAVIORAL), WL (BEHAVIORAL).
Who is sponsoring clinical trial NCT07216911?
This trial is sponsored by Trustees of Dartmouth College, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07216911's enrollment target sits among peer trials
2,000 52nd of 2000 higher than 1,947 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI